Streetbeat News

Stock Prices

MU

Semiconductor and chip stocks are experiencing a rise in share prices due to strong earnings reported by Micron.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2024 | 11:46 am

TRVI

Trevi Therapeutics will present data from its Phase 2A Canal Trial at CHEST 2024, focusing on cough relief in idiopathic pulmonary fibrosis patients treated with Nalbuphine ER.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2024 | 11:40 am

MU

Micron shares are trading higher after the company reported better-than-expected Q4 financial results.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2024 | 11:37 am

JBL

Jabil's Board of Directors has approved a share repurchase program of up to $1 billion. The buyback will be executed using various methods, including open market purchases, depending on market conditions.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2024 | 11:37 am

JBL

Jabil has released its Q1 fiscal year 2025 outlook, projecting net revenue between $6.3 billion and $6.9 billion, which is slightly below the $6.59 billion estimate. The company also expects adjusted EPS to range from $1.65 to $2.05, below the $2.22 estimate.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2024 | 11:34 am

JBL

Jabil reported its Q4 2024 financial results, surpassing analyst expectations with an adjusted EPS of $2.30 against the estimated $2.22, and sales of $6.964 billion compared to the expected $6.586 billion.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2024 | 11:31 am

JNVR

Janover Inc (NASDAQ: JNVR) has launched new AI tools to enhance its Insurtech subsidiary, Janover Insurance Group. These tools aim to improve sales and customer engagement, with plans for further AI advancements in 2024. JNVR stock rose 4.90% premarket.

Portfolio Pulse from Anusuya Lahiri

September 26, 2024 | 11:30 am

MU

PRGS

ZETA

Three tech stocks, Micron Technology, Progress Software, and Zeta Global, are currently overbought according to RSI indicators. Despite recent gains, investors should be cautious as these stocks may be at risk of a pullback.

Portfolio Pulse from Avi Kapoor

September 26, 2024 | 11:21 am

MSFT

OpenAI is transitioning to a for-profit model, potentially leading to a $150 billion valuation and a $10.5 billion payday for CEO Sam Altman. This move, backed by Microsoft, aims to attract more investors but has sparked controversy, including legal challenges from Elon Musk.

Portfolio Pulse from Rounak Jain

September 26, 2024 | 11:19 am

TFFP

TFF Pharmaceuticals has published preclinical data in the Journal of Drug Delivery Science and Technology, showcasing the superiority of its TFF technology for pulmonary drug delivery. The study highlights better drug distribution and rapid disaggregation of TFF powders compared to other methods.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2024 | 11:15 am